| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |